1 | A bill to be entitled |
2 | An act relating to the Asbestos and Silica Compensation |
3 | Fairness Act; amending s. 774.202, F.S.; revising purpose |
4 | of the act; amending s. 774.203, F.S.; revising |
5 | definitions; amending s. 774.204, F.S.; revising essential |
6 | elements of an asbestos or silica claim; revising persons |
7 | who may file or maintain certain civil actions alleging a |
8 | nonmalignant asbestos claim; revising and providing |
9 | evidence requirements; deleting a provision prohibiting |
10 | smokers from filing or maintaining certain asbestos |
11 | claims; deleting a provision prohibiting certain persons |
12 | from filing or maintaining a civil action alleging an |
13 | asbestos claim based on cancer of the colon, rectum, or |
14 | stomach; amending s. 774.205, F.S.; deleting a provision |
15 | requiring claimants to be domiciled in this state or claim |
16 | to have been exposed to asbestos or silica in this state; |
17 | revising information to be included in claims; amending s. |
18 | 774.206, F.S.; deleting a provision prohibiting damages |
19 | from being awarded for fear or risk of cancer in certain |
20 | civil actions; amending s. 774.207, F.S.; revising |
21 | prohibition on punitive damages; amending s. 774.208, |
22 | F.S.; deleting criteria a plaintiff must establish in |
23 | order to establish a product seller's liability; providing |
24 | an effective date. |
25 |
|
26 | WHEREAS, the crush of asbestos litigation has been costly |
27 | to employers, employees, litigants, and the court system, and |
28 | WHEREAS, in 1982, the Johns-Manville Corporation, the |
29 | nation's largest single supplier of insulation products |
30 | containing asbestos, declared bankruptcy due to the burden of |
31 | the asbestos litigation, and |
32 | WHEREAS, since 1982, more than 70 other companies have |
33 | reorganized due to the burden of asbestos litigation, and |
34 | WHEREAS, silica is a naturally occurring mineral, and |
35 | WHEREAS, the Earth's crust is over 90 percent silica, and |
36 | crystalline silica dust is the primary component of sand, |
37 | quartz, and granite, and |
38 | WHEREAS, silica-related illness, including silicosis, can |
39 | occur when tiny silica particles are inhaled, and |
40 | WHEREAS, silicosis was recognized as an occupational |
41 | disease many years ago, and |
42 | WHEREAS, the American Foundrymen's Society has distributed |
43 | literature for more than 100 years to its members warning of the |
44 | dangers of silica exposure, and |
45 | WHEREAS, the number of new lawsuits alleging silica-related |
46 | disease being filed each year began to rise precipitously in |
47 | recent years, and |
48 | WHEREAS, silica claims, like asbestos claims, often arise |
49 | when an individual is identified as having markings on his or |
50 | her lungs that are possibly consistent with silica exposure but |
51 | the individual has no functional or physical impairment from any |
52 | silica-related disease, and |
53 | WHEREAS, the Legislature finds that an overpowering public |
54 | necessity requires it to act to prevent a silica-based |
55 | litigation crisis, and |
56 | WHEREAS, concerns about statutes of limitations may prompt |
57 | claimants who have been exposed to asbestos or silica but who do |
58 | not have any current injury to bring premature lawsuits in order |
59 | to protect against losing their rights to future compensation |
60 | should they become impaired, and |
61 | WHEREAS, consolidations, joinders, and similar procedures |
62 | to which some courts have resorted in order to deal with the |
63 | mass of asbestos and silica cases can undermine the appropriate |
64 | functioning of the judicial process and further encourage the |
65 | filing of thousands of cases by exposed individuals who are not |
66 | sick and who may never become sick, and |
67 | WHEREAS, the Legislature finds that there is an |
68 | overpowering public necessity to defer the claims of exposed |
69 | individuals who are not sick in order to preserve, now and for |
70 | the future, defendants' ability to compensate people who develop |
71 | cancer and other serious asbestos-related and silica-related |
72 | injuries and to safeguard the jobs, benefits, and savings of |
73 | workers in this state and the well-being of the economy of this |
74 | state, NOW THEREFORE, |
75 |
|
76 | Be It Enacted by the Legislature of the State of Florida: |
77 |
|
78 | Section 1. Section 774.202, Florida Statutes, is amended |
79 | to read: |
80 | 774.202 Purpose.--It is the purpose of this act to: |
81 | (1) Ensure that persons who have demonstrable injuries as |
82 | a result of exposure to asbestos and silica are given their |
83 | constitutional right to access the court system Give priority to |
84 | true victims of asbestos and silica, claimants who can |
85 | demonstrate actual physical impairment caused by exposure to |
86 | asbestos or silica; and |
87 | (2) Ensure that the burden of medical monitoring and |
88 | health care are not shifted from the asbestos and silica |
89 | companies to Florida patients, health insurance companies, |
90 | employers, and the State Treasury. Fully preserve the rights of |
91 | claimants who were exposed to asbestos or silica to pursue |
92 | compensation if they become impaired in the future as a result |
93 | of the exposure; |
94 | (3) Enhance the ability of the judicial system to |
95 | supervise and control asbestos and silica litigation; and |
96 | (4) Conserve the scarce resources of the defendants to |
97 | allow compensation to cancer victims and others who are |
98 | physically impaired by exposure to asbestos or silica while |
99 | securing the right to similar compensation for those who may |
100 | suffer physical impairment in the future. |
101 | Section 2. Subsections (4), (18), (22), (23), (24), and |
102 | (25) of section 774.203, Florida Statutes, are amended to read: |
103 | 774.203 Definitions.--As used in this act, the term: |
104 | (4) "Asbestosis" means bilateral diffuse interstitial |
105 | pneumonitis and fibrosis caused by inhalation of the lungs |
106 | caused by inhalation of asbestos fibers. |
107 | (18) "Mesothelioma" means a malignant tumor with a primary |
108 | site in the pleura, or the peritoneum, or the pericardium or |
109 | tunica vaginalis testis, which has been diagnosed by a board- |
110 | certified pathologist, using standardized and accepted criteria |
111 | of microscopic morphology or appropriate staining techniques. |
112 | (22) "Predicted lower limit of normal" for any test means |
113 | below the reference values set by the American Thoracic Society |
114 | the fifth percentile of healthy populations based on age, |
115 | height, and gender, as referenced in the AMA Guides to the |
116 | Evaluation of Permanent Impairment. |
117 | (23) "Qualified physician" means a medical doctor, who: |
118 | (a) Is a board-certified pathologist licensed to practice |
119 | and actively practices in this country who performed services |
120 | requested or authorized by a physician who: |
121 | 1. Has conducted an evaluation of pathology materials |
122 | obtained from surgical or postmortem specimens a physical |
123 | examination of the exposed person or, if the person is deceased, |
124 | has reviewed all available records relating to the exposed |
125 | person's medical condition; |
126 | 2. Is actually treating or has treated the exposed person, |
127 | and has or had a doctor-patient relationship with the person; |
128 | and |
129 | 2.3. Is licensed to practice and actively practices in |
130 | this country; or |
131 | (b) Is a board-certified oncologist, pulmonary specialist, |
132 | or specialist in occupational and environmental medicine who: |
133 | 1. Has conducted a physical examination of the exposed |
134 | person or, if the person is deceased, has reviewed all available |
135 | records relating to the exposed person's medical condition; |
136 | 2. Is actually treating or has treated the exposed person, |
137 | and has or had a doctor-patient relationship with the person; |
138 | and |
139 | 2.3. Is licensed to practice and actively practices in |
140 | this country. |
141 | (24) "Radiological evidence of asbestosis" means a finding |
142 | on a quality 1 chest X ray under the ILO System of |
143 | classification (in a death case where no pathology is available, |
144 | the necessary radiologic findings may be made with a quality 2 |
145 | film if a quality 1 film is not available) showing small, |
146 | irregular opacities (s, t, u) graded by a certified B-reader of |
147 | 1/0 or higher as at least 1/1 on the ILO scale or such other |
148 | competent evidence of asbestosis on computed tomography by a |
149 | licensed physician. |
150 | (25) "Radiological evidence of diffuse pleural disease |
151 | thickening" means a finding on a quality 1 chest X ray or |
152 | computer tomography showing pleural plaques or pleural |
153 | thickening by a licensed physician under the ILO System of |
154 | classification (in a death case where no pathology is available, |
155 | the necessary radiologic findings may be made with a quality 2 |
156 | film if a quality 1 film is not available) showing bilateral |
157 | pleural thickening of at least B2 on the ILO scale and blunting |
158 | of at least one costophrenic angle. |
159 | Section 3. Section 774.204, Florida Statutes, is amended |
160 | to read: |
161 | 774.204 Physical impairment.-- |
162 | (1) Physical impairment or death of the exposed person, to |
163 | which asbestos or silica exposure was a substantial contributing |
164 | factor, is an essential element of an asbestos or silica claim. |
165 | (2) A person may not file or maintain a civil action |
166 | alleging a nonmalignant asbestos claim in the absence of a prima |
167 | facie showing of physical impairment or death as a result of a |
168 | medical condition to which exposure to asbestos was a |
169 | substantial contributing factor. The prima facie showing must |
170 | include all of the following requirements: |
171 | (a) Evidence verifying that a qualified physician, or |
172 | someone working under the direct supervision and control of a |
173 | qualified physician, has taken a detailed occupational and |
174 | exposure history of the exposed person or, if the person is |
175 | deceased, from a person who is knowledgeable about the exposures |
176 | that form the basis of the nonmalignant asbestos claim, |
177 | including: |
178 | 1. Identification of all of the exposed person's pertinent |
179 | principal places of employment and exposures to airborne |
180 | contaminants; and |
181 | 2. Whether each place of employment involved exposures to |
182 | airborne contaminants, including but not limited to asbestos |
183 | fibers or other disease-causing dusts, that can cause pulmonary |
184 | impairment and the nature, duration, and level of any such |
185 | exposure, if known. |
186 | (b) Evidence verifying that a qualified physician, or |
187 | someone working under the direct supervision and control of a |
188 | qualified physician, has taken a detailed medical and smoking |
189 | history, including a thorough review of the exposed person's |
190 | past and present medical problems and their most probable cause. |
191 | (c) Evidence sufficient to demonstrate that at least 10 |
192 | years have elapsed between the date of first exposure to |
193 | asbestos and the date the diagnosis is made. |
194 | (d) In the case of a living person, a determination by a |
195 | qualified physician that the exposed person is impaired as |
196 | defined by Official Statements of the American Thoracic Society, |
197 | on the basis of a medical examination and pulmonary function |
198 | testing, that the exposed person has a permanent respiratory |
199 | impairment rating of at least Class 2 as defined by and |
200 | evaluated pursuant to the AMA Guides to the Evaluation of |
201 | Permanent Impairment. |
202 | (e) A diagnosis by a qualified physician of asbestosis or |
203 | asbestos-related diffuse pleural disease thickening, based at a |
204 | minimum on radiological or pathological evidence of asbestosis |
205 | or radiological evidence of asbestos-related diffuse pleural |
206 | disease thickening. |
207 | (f) In the case of a living person, a determination by a |
208 | qualified physician that asbestosis or asbestos-related diffuse |
209 | pleural disease thickening, rather than chronic obstructive |
210 | pulmonary disease, is a substantial contributing factor to the |
211 | exposed person's physical impairment, as defined by Official |
212 | Statements of the American Thoracic Society. based at a minimum |
213 | on a determination that the exposed person has: |
214 | 1. Total lung capacity, by plethysmography or timed gas |
215 | dilution, below the predicted lower limit of normal; |
216 | 2. Forced vital capacity below the lower limit of normal |
217 | and a ratio of FEV1 to FVC that is equal to or greater than the |
218 | predicted lower limit of normal; or |
219 | 3. A chest X ray showing small, irregular opacities (s, t, |
220 | u) graded by a certified B-reader as at least 2/1 on the ILO |
221 | scale. |
222 | (g) If the exposed person meets the requirements of |
223 | paragraphs (a), (b), and (c), and if a qualified physician |
224 | determines that the exposed person has a physical impairment, as |
225 | demonstrated by meeting the criteria set forth in paragraph (d) |
226 | and subparagraph (f)1. or subparagraph (f)2., but the exposed |
227 | person's chest X ray does not demonstrate radiological evidence |
228 | of asbestosis, the exposed person may meet the criteria of |
229 | paragraph (e) if his or her chest X ray is graded by a certified |
230 | B-reader as at least 1/0 and a qualified physician, relying on |
231 | high-resolution computed tomography, determines to a reasonable |
232 | degree of medical certainty that the exposed person has |
233 | asbestosis and forms the conclusion set forth in paragraph (h). |
234 | (g)(h) A conclusion by a qualified physician that the |
235 | exposed person's exposure to asbestos was a substantial |
236 | contributing cause of the exposed person's medical findings, and |
237 | impairment, or death were not more probably the result of causes |
238 | other than the asbestos exposure revealed by the exposed |
239 | person's employment and medical history. A diagnosis that states |
240 | that the medical findings and impairment are "consistent with" |
241 | or "compatible with" exposure to asbestos does not meet the |
242 | requirements of this subsection. |
243 | (h)(i) If a plaintiff files a civil action alleging a |
244 | nonmalignant asbestos claim, and that plaintiff alleges that his |
245 | or her exposure to asbestos was the result of extended contact |
246 | with another exposed person who, if the civil action had been |
247 | filed by the other exposed person, would have met the |
248 | requirements of paragraph (a), and the plaintiff alleges that he |
249 | or she had extended contact with the exposed person during the |
250 | time period in which that exposed person met the requirements of |
251 | paragraph (a), the plaintiff has satisfied the requirements of |
252 | paragraph (a). The plaintiff in such a civil action must |
253 | individually satisfy the requirements of paragraphs (b), (c), |
254 | (d), (e), (f), and (g), and (h). |
255 | (3) A person who is a smoker may not file or maintain a |
256 | civil action alleging an asbestos claim which is based upon |
257 | cancer of the lung, larynx, pharynx, or esophagus in the absence |
258 | of a prima facie showing that includes all of the following |
259 | requirements: |
260 | (a) A diagnosis by a qualified physician who is board |
261 | certified in pathology, pulmonary medicine, or oncology, as |
262 | appropriate for the type of cancer claimed, of a primary cancer |
263 | of the lung, larynx, pharynx, or esophagus, and that exposure to |
264 | asbestos was a substantial contributing factor to the condition. |
265 | (b) Evidence sufficient to demonstrate that at least 10 |
266 | years have elapsed between the date of first exposure to |
267 | asbestos and the date of diagnosis of the cancer. |
268 | (c) Radiological or pathological evidence of asbestosis or |
269 | diffuse pleural thickening or a qualified physician's diagnosis |
270 | of asbestosis based on a chest X ray graded by a certified B- |
271 | reader as at least 1/0 on the ILO scale and high-resolution |
272 | computed tomography supporting the diagnosis of asbestosis to a |
273 | reasonable degree of medical certainty. |
274 | (d) Evidence of the exposed person's substantial |
275 | occupational exposure to asbestos. If a plaintiff files a civil |
276 | action alleging an asbestos-related claim based on cancer of the |
277 | lung, larynx, pharynx, or esophagus, and that plaintiff alleges |
278 | that his or her exposure to asbestos was the result of extended |
279 | contact with another exposed person who, if the civil action had |
280 | been filed by the other exposed person, would have met the |
281 | substantial occupational exposure requirement of this |
282 | subsection, and the plaintiff alleges that he or she had |
283 | extended contact with the exposed person during the time period |
284 | in which that exposed person met the substantial occupational |
285 | exposure requirement of this subsection, the plaintiff has |
286 | satisfied the requirements of this paragraph. The plaintiff in |
287 | such a civil action must individually satisfy the requirements |
288 | of this subsection. |
289 | (e) If the exposed person is deceased, the qualified |
290 | physician, or someone working under the direct supervision and |
291 | control of a qualified physician, may obtain the evidence |
292 | required in paragraphs (b) and (d) from the person most |
293 | knowledgeable about the alleged exposures that form the basis of |
294 | the asbestos claim. |
295 | (f) A conclusion by a qualified physician that the exposed |
296 | person's medical findings and impairment were not more probably |
297 | the result of causes other than the asbestos exposure revealed |
298 | by the exposed person's employment and medical history. A |
299 | conclusion that the medical findings and impairment are |
300 | "consistent with" or "compatible with" exposure to asbestos does |
301 | not meet the requirements of this subsection. |
302 | (3)(4) In a civil action alleging an asbestos claim by a |
303 | nonsmoker based on cancer of the lung, larynx, colon, rectum, |
304 | stomach, pharynx, or esophagus, a prima facie showing of an |
305 | impairment due to asbestos exposure is not required. |
306 | (5) A person may not file or maintain a civil action |
307 | alleging an asbestos claim which is based on cancer of the |
308 | colon, rectum, or stomach in the absence of a prima facie |
309 | showing that includes all of the following requirements: |
310 | (a) A diagnosis by a qualified physician who is board |
311 | certified in pathology, pulmonary medicine, or oncology, as |
312 | appropriate for the type of cancer claimed, of cancer of the |
313 | colon, rectum, or stomach, and that exposure to asbestos was a |
314 | substantial contributing factor to the condition. |
315 | (b) Evidence sufficient to demonstrate that at least 10 |
316 | years have elapsed between the date of first exposure to |
317 | asbestos and the date of diagnosis of the cancer. |
318 | (c)1.a. Radiological or pathological evidence of |
319 | asbestosis or diffuse pleural thickening or a qualified |
320 | physician's diagnosis of asbestosis based on a chest X ray |
321 | graded by a certified B-reader as at least 1/0 on the ILO scale |
322 | and high-resolution computed tomography supporting the diagnosis |
323 | of asbestosis to a reasonable degree of medical certainty; or |
324 | b. Evidence of the exposed person's substantial |
325 | occupational exposure to asbestos. If a plaintiff files a civil |
326 | action alleging an asbestos-related claim based on cancer of the |
327 | colon, rectum, or stomach, and that plaintiff alleges that his |
328 | or her exposure to asbestos was the result of extended contact |
329 | with another exposed person who, if the civil action had been |
330 | filed by the other exposed person, would have met the |
331 | substantial occupational exposure requirement of this |
332 | subsection, and the plaintiff alleges that he or she had |
333 | extended contact with the exposed person during the time period |
334 | in which that exposed person met the substantial occupational |
335 | exposure requirement of this subsection, the plaintiff has |
336 | satisfied the requirements of this sub-subparagraph. The |
337 | plaintiff in such a civil action must individually satisfy the |
338 | requirements of this subsection. |
339 | 2. In the case of an exposed person who is a smoker, the |
340 | criteria in sub-subparagraph 1.a. and b. must be met. |
341 | 3. If the exposed person is deceased, the qualified |
342 | physician, or someone working under the direct supervision and |
343 | control of a qualified physician, may obtain the evidence |
344 | required in sub-subparagraph 1.b. and paragraph (b) from the |
345 | person most knowledgeable about the alleged exposures that form |
346 | the basis of the asbestos claim. |
347 | (d) A conclusion by a qualified physician that the exposed |
348 | person's medical findings and impairment were not more probably |
349 | the result of causes other than the asbestos exposure revealed |
350 | by the exposed person's employment and medical history. A |
351 | conclusion that the medical findings and impairment are |
352 | "consistent with" or "compatible with" exposure to asbestos does |
353 | not meet the requirements of this subsection. |
354 | (4)(6) In a civil action alleging an asbestos claim based |
355 | upon mesothelioma a prima facie showing of an impairment due to |
356 | asbestos exposure is not required. |
357 | (5)(7) A person may not file or maintain a civil action |
358 | alleging a silicosis claim in the absence of a prima facie |
359 | showing of physical impairment as a result of a medical |
360 | condition to which exposure to silica was a substantial |
361 | contributing factor. The prima facie showing must include all of |
362 | the following requirements: |
363 | (a) Evidence verifying that a qualified physician, or |
364 | someone working under the direct supervision and control of a |
365 | qualified physician, has taken a detailed occupational and |
366 | exposure history of the exposed person or, if the person is |
367 | deceased, from a person who is knowledgeable about the exposures |
368 | that form the basis of the nonmalignant silica claim, including: |
369 | 1. All of the exposed person's principal places of |
370 | employment and exposures to airborne contaminants; and |
371 | 2. Whether each place of employment involved exposures to |
372 | airborne contaminants, including, but not limited to, silica |
373 | particles or other disease-causing dusts, that can cause |
374 | pulmonary impairment and the nature, duration, and level of any |
375 | such exposure. |
376 | (b) Evidence verifying that a qualified physician, or |
377 | someone working under the direct supervision and control of a |
378 | qualified physician, has taken detailed medical and smoking |
379 | history, including a thorough review of the exposed person's |
380 | past and present medical problems and their most probable cause, |
381 | and verifying a sufficient latency period for the applicable |
382 | stage of silicosis. |
383 | (c) A determination by a qualified physician, on the basis |
384 | of a medical examination and pulmonary function testing, that |
385 | the exposed person has a permanent respiratory impairment rating |
386 | of at least Class 2 as defined by and evaluated pursuant to the |
387 | AMA Guides to the Evaluation of Permanent Impairment. |
388 | (d) A determination by a qualified physician that the |
389 | exposed person has: |
390 | 1. A quality 1 chest X ray under the ILO System of |
391 | classification and that the X ray has been read by a certified |
392 | B-reader as showing, according to the ILO System of |
393 | classification, bilateral nodular opacities (p, q, or r) |
394 | occurring primarily in the upper lung fields, graded 1/1 or |
395 | higher; or |
396 | 2. Pathological demonstration of classic silicotic nodules |
397 | exceeding one centimeter in diameter as published in 112 Archive |
398 | of Pathology and Laboratory Medicine 7 (July 1988). |
399 |
|
400 | In a death case where no pathology is available, the necessary |
401 | radiologic findings may be made with a quality 2 film if a |
402 | quality 1 film is not available. |
403 | (e) A conclusion by a qualified physician that the exposed |
404 | person's medical findings and impairment were not more probably |
405 | the result of causes other than silica exposure revealed by the |
406 | exposed person's employment and medical history. A conclusion |
407 | that the medical findings and impairment are "consistent with" |
408 | or "compatible with" exposure to silica does not meet the |
409 | requirements of this subsection. |
410 | (6)(8) A person may not file or maintain a civil action |
411 | alleging a silica claim other than as provided in subsection (5) |
412 | (7), in the absence of a prima facie showing that includes all |
413 | of the following requirements: |
414 | (a) A report by a qualified physician who is: |
415 | 1. Board certified in pulmonary medicine, internal |
416 | medicine, oncology, or pathology stating a diagnosis of the |
417 | exposed person of silica-related lung cancer and stating that, |
418 | to a reasonable degree of medical probability, exposure to |
419 | silica was a substantial contributing factor to the diagnosed |
420 | lung cancer; or |
421 | 2. Board certified in pulmonary medicine, internal |
422 | medicine, or pathology stating a diagnosis of the exposed person |
423 | of silica-related progressive massive fibrosis or acute |
424 | silicoproteinosis, or silicosis complicated by documented |
425 | tuberculosis. |
426 | (b) Evidence verifying that a qualified physician, or |
427 | someone working under the direct supervision and control of a |
428 | qualified physician, has taken a detailed occupational and |
429 | exposure history of the exposed person or, if the person is |
430 | deceased, from a person who is knowledgeable about the exposures |
431 | that form the basis of the nonmalignant silica claim, including: |
432 | 1. All of the exposed person's principal places of |
433 | employment and exposures to airborne contaminants; and |
434 | 2. Whether each place of employment involved exposures to |
435 | airborne contaminants, including, but not limited to, silica |
436 | particles or other disease-causing dusts, that can cause |
437 | pulmonary impairment and the nature, duration, and level of any |
438 | such exposure. |
439 | (c) Evidence verifying that a qualified physician, or |
440 | someone working under the direct supervision and control of a |
441 | qualified physician, has taken a detailed medical and smoking |
442 | history, including a thorough review of the exposed person's |
443 | past and present medical problems and their most probable cause; |
444 | (d) A determination by a qualified physician that the |
445 | exposed person has: |
446 | 1. A quality 1 chest X ray under the ILO System of |
447 | classification and that the X ray has been read by a certified |
448 | B-reader as showing, according to the ILO System of |
449 | classification, bilateral nodular opacities (p, q, or r) |
450 | occurring primarily in the upper lung fields, graded 1/1 or |
451 | higher; or |
452 | 2. Pathological demonstration of classic silicotic nodules |
453 | exceeding one centimeter in diameter as published in 112 Archive |
454 | of Pathology and Laboratory Medicine 7 (July 1988). |
455 |
|
456 | In a death case where no pathology is available, the necessary |
457 | radiologic findings may be made with a quality 2 film if a |
458 | quality 1 film is not available. |
459 | (e) A conclusion by a qualified physician that the exposed |
460 | person's medical findings and impairment were not more probably |
461 | the result of causes other than silica exposure revealed by the |
462 | exposed person's employment and medical history. A conclusion |
463 | that the medical findings and impairment are "consistent with" |
464 | or "compatible with" exposure to silica does not meet the |
465 | requirements of this subsection. |
466 | (7)(9) Evidence relating to physical impairment under this |
467 | section, including pulmonary function testing and diffusing |
468 | studies, must: |
469 | (a) Comply with the Official Statements of the American |
470 | Thoracic Society technical recommendations for examinations, |
471 | testing procedures, quality assurance, quality control, and |
472 | equipment of the AMA Guides to the Evaluation of Permanent |
473 | Impairment, as set forth in 20 C.F.R. part 404, Subpart P. App. |
474 | 1. Part A, s. 3.00 E. and F., and the interpretive standards, |
475 | set forth in the official statement of the American Thoracic |
476 | Society entitled "lung function testing: selection of reference |
477 | values and interpretive strategies" as published in American |
478 | Review of Respiratory Disease. 1991: 144:1202-1218; |
479 | (b) Not be obtained through testing or examinations that |
480 | violate any applicable law, regulation, licensing requirement, |
481 | or medical code of practice; and |
482 | (c) Not be obtained under the condition that the exposed |
483 | person retain legal services in exchange for the examination, |
484 | test, or screening. |
485 | (8)(10) Presentation of prima facie evidence meeting the |
486 | requirements of subsection (2), subsection (3), subsection (5), |
487 | or subsection (4) (6) of this section may not: |
488 | (a) Result in any presumption at trial that the exposed |
489 | person is impaired by an asbestos-related or silica-related |
490 | condition; |
491 | (b) Be conclusive as to the liability of any defendant; |
492 | and |
493 | (c) Be admissible at trial. |
494 | Section 4. Section 774.205, Florida Statutes, is amended |
495 | to read: |
496 | 774.205 Claimant proceedings.-- |
497 | (1) A civil action alleging an asbestos or silica claim |
498 | may be brought in the courts of this state if the plaintiff is |
499 | domiciled in this state or the exposure to asbestos or silica |
500 | that is a substantial contributing factor to the physical |
501 | impairment of the plaintiff on which the claim is based occurred |
502 | in this state. |
503 | (1)(2) A plaintiff in a civil action alleging an asbestos |
504 | or silica claim must include with the complaint or other initial |
505 | pleading a written report and supporting test results |
506 | constituting prima facie evidence of the exposed person's |
507 | asbestos-related or silica-related physical impairment meeting |
508 | the requirements of s. 774.204(2), (3), (5), or (4)(6). For any |
509 | asbestos or silica claim pending on the effective date of this |
510 | act, the plaintiff must file the report and supporting test |
511 | results at least 30 days before setting a date for trial. The |
512 | defendant must be afforded a reasonable opportunity to challenge |
513 | the adequacy of the proffered prima facie evidence of asbestos- |
514 | related impairment. The claim of the plaintiff shall be |
515 | dismissed without prejudice upon a finding of failure to make |
516 | the required prima facie showing. |
517 | (2)(3) All asbestos claims and silica claims filed in this |
518 | state on or after the effective date of this act must include, |
519 | in addition to the written report described in subsection (1) |
520 | (2) and the information required by s. 774.207(2), a sworn |
521 | information form containing the following information: |
522 | (a) The claimant's name, address, date of birth, and |
523 | marital status; |
524 | (b) If the claimant alleges exposure to asbestos or silica |
525 | through the testimony of another person or alleges other than |
526 | direct or bystander exposure to a product, the name, address, |
527 | date of birth, and marital status for each person by which the |
528 | claimant alleges exposure, hereinafter the "index person," and |
529 | the claimant's relationship to each such person; |
530 | (c) The specific location of each alleged exposure; |
531 | (d) The beginning and ending dates of each alleged |
532 | exposure as to each asbestos product or silica product for each |
533 | location at which exposure allegedly took place for the |
534 | plaintiff and each index person; |
535 | (e) The occupation and name of the employer of the exposed |
536 | person at the time of each alleged exposure; |
537 | (b)(f) The specific condition related to asbestos or |
538 | silica claimed to exist; and |
539 | (c)(g) Any supporting documentation of the condition |
540 | claimed to exist. |
541 | Section 5. Subsection (2) of section 774.206, Florida |
542 | Statutes, is amended to read: |
543 | 774.206 Statute of limitations; two-disease rule.-- |
544 | (2) An asbestos or silica claim arising out of a |
545 | nonmalignant condition shall be a distinct cause of action from |
546 | an asbestos or silica claim relating to the same exposed person |
547 | arising out of asbestos-related or silica-related cancer. |
548 | Damages may not be awarded for fear or risk of cancer in a civil |
549 | action asserting an asbestos or silica claim. |
550 | Section 6. Subsection (1) of section 774.207, Florida |
551 | Statutes, is amended to read: |
552 | 774.207 Scope of liability; damages.-- |
553 | (1) Punitive damages may not be awarded in any civil |
554 | action alleging an asbestos or silica claim in accordance with |
555 | the laws of the state. |
556 | Section 7. Section 774.208, Florida Statutes, is amended |
557 | to read: |
558 | 774.208 Liability rules applicable to protect sellers, |
559 | renters, and lessors.-- |
560 | (1)(a) In a civil action alleging an asbestos or silica |
561 | claim, a product seller other than a manufacturer is liable to a |
562 | plaintiff only if the plaintiff establishes that: |
563 | 1.a. The product that allegedly caused the harm that is |
564 | the subject of the complaint was sold, rented, or leased by the |
565 | product seller; |
566 | b. The product seller failed to exercise reasonable care |
567 | with respect to the product; and |
568 | c. The failure to exercise reasonable care was a proximate |
569 | cause of the harm to the exposed person; |
570 | 2.a. The product seller made an express warranty |
571 | applicable to the product that allegedly caused the harm that is |
572 | the subject of the complaint, independent of any express |
573 | warranty made by the manufacturer as to the same product; |
574 | b. The product failed to conform to the warranty; and |
575 | c. The failure of the product to conform to the warranty |
576 | caused the harm to the exposed person; or |
577 | 3.a. The product seller engaged in intentional wrongdoing, |
578 | as determined under the law of this state; and |
579 | b. The intentional wrongdoing caused the harm that is the |
580 | subject of the complaint. |
581 | (b) For the purpose of sub-subparagraph (a)1.b., a product |
582 | seller may not be considered to have failed to exercise |
583 | reasonable care with respect to a product based upon an alleged |
584 | failure to inspect the product, if: |
585 | 1. The failure occurred because there was no reasonable |
586 | opportunity to inspect the product; or |
587 | 2. The inspection, in the exercise of reasonable care, |
588 | would not have revealed the aspect of the product which |
589 | allegedly caused the exposed person's impairment. |
590 | (2) In a civil action alleging an asbestos or silica |
591 | claim, a person engaged in the business of renting or leasing a |
592 | product is not liable for the tortious act of another solely by |
593 | reason of ownership of that product. |
594 | Section 8. This act shall take effect July 1, 2009. |